Dark

KPTI
Karyopharm Therapeutics Inc.
stock NASDAQ

At Close

Jul 30, 2026 3:59:57 PM EDT

6.99USD+1.968%(+0.13)1,603,964

6.04Bid 8.40Ask 2.36Spread

Pre-market

Jul 30, 2026 9:28:30 AM EDT

6.99USD+1.822%(+0.13)469

After-hours

Jul 30, 2026 4:59:30 PM EDT

2.77USD-60.400%(-4.22)652,584

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

158.98M

CEO

Michael Kauffman

Headquarters

Newton Center, Massachusetts, USA

Industry

Biotechnology

Next Earnings

Aug 10, 2026 (11d)

Last Split

Feb 26, 20251for15reverse

IMMU EXEL ECYT ABT BMY MRK XLV

KPTI Stats

Avg. Vol. 10 Day

750,454

Avg. Vol. 30 Day

616,696

Employees

154

Market Cap

158,980,545

Shares Out.

22,662,943

On/Off Exchange

66%/34%

6 Month Beta

0.30

1 Year Beta

0.89

2 Year Beta

0.82

3 Year Beta

0.93

52 Week Low

3.65

52 Week High

10.99

SMA50

8.94

SMA200

7.64

1 Week

-1.06%

1 Month

-28.20%

3 Month

-15.58%

6 Month

+7.59%

1 Year

+73.21%

2 Year

-55.88%

5 Year

-94.39%

Profile

karyopharm therapeutics inc. is a clinical-stage pharmaceutical company focused on discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. for more information, please visit www.karyopharm.com

KPTI Stock Summary

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) stock price today is $6.99, and today's volume is 1,603,964. KPTI is up 1.968% today. The 30 day average volume is 616,696. KPTI market cap is 158.98M with 22,662,943 shares outstanding.

.dark-mode .tSl4fv{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .tSl4fv{ color: #333333; background-color: white; border: 2px solid #333333; }KPTIKaryopharm Therapeutics Inc.stock NASDAQ

KPTI Stock Summary

KPTI
Karyopharm Therapeutics Inc.
stock NASDAQ